Clinical Trial

Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study will explore the potential effects of high-fat meal on the plasma pharmacokinetics (PK) of CRS3123 when administered as a single oral dose of 200 mg in healthy adult participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-16; most recent amendment 2026-03-17.
Status change: Active, Not Recruiting → Completed 2025-06-11
Trial Details
NCT Number NCT06988423
Lead Sponsor Crestone, Inc
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Food Effect in Healthy Participants
Enrollment 17 participants
Start Date 2025-04-21
Primary Completion 2025-06-04 (estimated)
Study Completion 2025-06-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-18